Skip to main content
. 2020 Apr 20;20(3):foaa019. doi: 10.1093/femsyr/foaa019

Table 4.

Plasmids used in this study.

Name Relevant characteristics Reference
pJR030a 2 µm, KanR, URA3, pPGK1-CdtG-tENO1 This study
pJR032a 2 µm, KanR, URA3, pPGK1-CltA-tENO1 This study
pJR034a 2 µm, KanR, URA3, pPGK1-An14g01600-tENO1 This study
pJR035a 2 µm, KanR, URA3, pPGK1-An16g06220-tENO1 This study
pJR036a 2 µm, KanR, URA3, pPGK1-An08g09350-tENO1 This study
pJR037a 2 µm, KanR, URA3, pPGK1-An13g03250-tENO1 This study
pJR038a 2 µm, KanR, URA3, pPGK1-An03g05320-tENO1 This study
pJR040a 2 µm, KanR, URA3, pPGK1-Ls120451-tENO1 This study